Related Experiment Video
Updated: Jun 10, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Diagnosis of patients with suspected chronic hepatitis C infection
Adrián Gadano1, Omar Galdame, Sebastián Marciano
1Sección Hepatología, Hospital Italiano de Buenos Aires-Argentina, Ciudad de Buenos Aires, Argentina. adrian.gadano@hospitalitaliano.org.ar
Insights
Detecting hepatitis C virus (HCV) involves risk factor screening. Current tests diagnose and monitor treatment but do not assess disease severity or prognosis for HCV infection.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) infection is primarily detected through risk-based screening.
- Transmission routes include blood transfusions, unsafe injections, and intravenous drug use.
- Current diagnostic strategies focus on identifying at-risk populations for targeted testing.
Purpose of the Study:
- To outline the optimal approach for detecting hepatitis C virus (HCV) infection.
- To detail the available virological markers for clinical management.
- To clarify the limitations of current diagnostic and monitoring tools.
Main Methods:
- Review of current screening protocols for HCV infection.
- Analysis of serologic assays (ELISA, immunoblot) for anti-HCV antibodies.
- Evaluation of virological assays for serum HCV RNA detection (qualitative and quantitative).
Main Results:
- Optimal HCV detection relies on screening individuals with identified risk factors.
- Serologic and virologic assays are effective for diagnosis and treatment monitoring.
- These tests do not provide information on disease severity or patient prognosis.
Conclusions:
- Risk-factor-based screening remains the primary strategy for HCV detection.
- Existing assays are crucial for diagnosis and monitoring but limited in prognostic assessment.
- Patient education on preventing disease spread is essential post-diagnosis.
Abstract:
The current optimal approach to detecting hepatitis C virus (HCV) infection involves screening people for risk factors and only testing selected individuals at risk. Blood transfusion from infectious donors, unsafe therapeutic injection practices, and illegal intravenous drug use have been the predominant modes of transmission of HCV infection. Virological markers that are currently used for the clinical management of patients with hepatitis C include serologic assays (ELISA or immunoblot assays), which detect specific antibodies (IgG) to HCV, and virological assays, which detect serum HCV RNA, by highly sensitive qualitative and quantitative techniques. The applicability of these tests is for the diagnoses and monitoring of the treatment but they have no role in the assessment of disease severity or prognosis. Patients diagnosed with HCV infection must be educated in order to avoid the spread of the disease to other people.
More Related Videos
10:25"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Viral Hepatitis I: Introduction
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction